Pressure BioSciences, Inc.
PBIO
$0.0042
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 20.76% | 11.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.76% | 11.81% | |||
| Cost of Revenue | 61.81% | -30.04% | |||
| Gross Profit | -61.78% | 646.70% | |||
| SG&A Expenses | 26.20% | -57.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 28.17% | -51.79% | |||
| Operating Income | -29.90% | 57.48% | |||
| Income Before Tax | 11.86% | 18.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.86% | 18.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.86% | 18.47% | |||
| EBIT | -29.90% | 57.48% | |||
| EBITDA | -30.53% | 59.32% | |||
| EPS Basic | 31.09% | 32.87% | |||
| Normalized Basic EPS | 38.03% | -6.63% | |||
| EPS Diluted | 31.09% | 32.87% | |||
| Normalized Diluted EPS | 38.03% | -6.63% | |||
| Average Basic Shares Outstanding | 29.14% | 23.12% | |||
| Average Diluted Shares Outstanding | 29.14% | 23.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||